Verge HealthTech Fund

www.verge.fund

VCMatch tracks Verge HealthTech Fund as an investor focused on Digital Health, AI/ML, and Medtech companies, Seed and Series A rounds, and Global, Bangladesh, and Taiwan markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Seed, Series A, Growth

Focus Areas

Digital Health, AI/ML, Medtech

Geography

global, Bangladesh, and Taiwan

Investment Thesis

The firm believes healthtech is the primary lever to “extend healthspan for all” by making healthcare exponentially more efficient and effective. They state that “Healthtech is technology that amplifies any aspect of the current healthcare system” and they “invest in transformative technology that makes healthcare more accessible, better in quality, and more efficient.” Their thesis targets technologies that solve large unmet needs in health and platforms that can reach millions, with an emphasis on backing founders at the seed to Series A transition and scaling them through operator-led support, portfolio synergies, and a global ecosystem.

Is Verge HealthTech Fund right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Verge HealthTech Fund is most relevant for founders raising Seed, Series A, and Growth rounds in Digital Health, AI/ML, Medtech, and Enterprise SaaS, especially across global, Bangladesh, and Taiwan.

Focus statement

Geo-agnostic early-stage (Seed to Series A) healthtech investments across AI & data analytics, next-gen diagnostics, breakthrough smart devices, digital health platforms, digital therapeutics, and healthcare SaaS — prioritising solutions that address large unmet needs and can reach millions.

Value Add

Operator-investor team: the firm highlights a team of "Operator-investors who have all built startups, spent years in both healthcare and technology industries, and have extensive global networks."
Active, hands-on approach: repeatedly described as "Active Expertise" and "early and active partners of startups" who "actively partner with founders crossing the chasm from early to growth stage."
Portfolio synergies: explicit collaboration across portfolio companies on "R&D, commercial distribution, clinical trials, among others."
Global Ecosystem: offers "Access to Verge’s global network of leading companies, investors, and institutions to help your company scale."
Clear stage & scope focus: explicit Seed to Series A and "Geo - Agnostic" mandate focused exclusively on healthtech.
Outcome-driven framing: frames investments around extending healthspan and solving "large unmet needs in health," not just incremental product plays.